Role of the Activation Loop Tyrosines in Regulation of the Insulin-like Growth Factor I Receptor-tyrosine Kinase

This publication has 28 references indexed in Scilit:

• In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase
  Cancer Cell, 2004
• Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
  Cancer Cell, 2004
• Crystal Structure of the Apo, Unactivated Insulin-like Growth Factor-1 Receptor Kinase
  Journal of Biological Chemistry, 2002
• Crystal Structure of Bisphosphorylated IGF-1 Receptor Kinase
  Structure, 2001
• Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
  Science, 2000
• Autophosphorylation Dependent Destabilization of the Insulin Receptor Kinase Domain: Tryptophan-1175 Reports Changes in the Catalytic Cleft
  Biochemistry, 1999
• Conformational changes in the activation loop of the insulin receptor's kinase domain
  Protein Science, 1999
• The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis
  Journal of Biological Chemistry, 1995
• Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis
  Endocrinology, 1995
• Insulin-Like Growth Factors
  Neurosignals, 1992